Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Biomarkers in Tears May Help Diagnose Parkinson’s Disease

Publish date:: May 14, 2019

Key clinical point: Noninvasive measurement of biomarkers in tears may help to diagnose Parkinson’s disease.

Major finding: The amount of oligomeric alpha synuclein was almost five times higher in patients than in controls.

Study details: A prospective collection of reflex tears from 165 patients with and without Parkinson’s disease.

Disclosures: Dr. Lew reported receiving research support from the Parkinson’s Study Group, the Michael J. Fox Foundation, Biotie Therapies, NeuroDerm, Enterin, Pharm2B Fellowship Grants, Allergan, and Medtronic.

Citation:

Lew M et al. AAN 2019, Abstract S10.001.

This Week's Must Reads

Sleep problems in young children linked to lower QOL in later years,

Hypertension often goes undertreated in patients with a history of stroke,

Health disparities training falls short for internal medicine residents,

Many children with COVID-19 present without classic symptoms,

In epilepsy, brain-responsive stimulation passes long-term tests,

Must Reads in Movement Disorders

Can DBS in early Parkinson’s disease reduce disease progression?,

Huntington's disease biomarkers appear 24 years before clinical symptoms,

Nilotinib is safe in moderate and advanced Parkinson’s disease,

GI symptoms in Parkinson’s disease correlate with less microbial diversity,

Researchers identify a cause of L-DOPA–induced dyskinesia in Parkinson’s disease,

Neurology

Neurology

Biomarkers in Tears May Help Diagnose Parkinson’s Disease

This Week's Must Reads

Must Reads in Movement Disorders